About

BioAgilytix provides specialized bioanalytical testing services for the pharmaceutical, biotechnology, and agricultural biotechnology industries. Their services include a variety of assays, such as pharmacokinetics (PK) and pharmacodynamics (PD) assays, which analyze how drugs behave in the body, as well as cell-based assays that test drug effects on living cells and immunogenicity assays that assess immune responses to drugs. With a strong presence in Europe, particularly through their Hamburg laboratory, BioAgilytix supports clients in developing and validating new treatments and ensuring the safety of agricultural products. They also offer customizable COVID-19 testing packages. Unlike many competitors, BioAgilytix focuses specifically on large molecule studies, making them a crucial partner for companies in the life sciences sector. Their goal is to facilitate the development and approval of new drugs and therapies, contributing to advancements in healthcare and agriculture.

Simplify's Take

What believers are saying

• Increased demand for personalized medicine boosts need for specialized bioanalytical testing.
• Growing market for biosimilars and biobetters requires rigorous testing services.
• Expansion of Hamburg lab enhances genetic testing capabilities in Europe.

What critics are saying

• Cancellation of Durham expansion deal may impact growth and job creation.
• Regulatory challenges may arise in launching Stockholm3 prostate cancer test in the US.
• Leadership changes could lead to strategic shifts disrupting current operations.

What makes BioAgilytix unique

• Specializes in immunoassays and cell-based assays for large molecule studies.
• Global presence with labs in North Carolina and Hamburg, Germany.
• Offers comprehensive suite of assays including PK, PD, and immunogenicity assays.

Help us improve and share your feedback! Did you find this helpful?

YesNo